Pharmaceutical company Novartis is laying off more than 400 employees at its East Hanover facility as part of a restructuring ...

Cosentyx (secukinumab ... always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended ...

It’s two years since Novartis got its Cosentyx IL-17 drug approved for the spinal disease ankylosing spondylitis, and the Swiss pharma company has new data that it hopes will allow it to compete ...

Incyte has delivered a pair of pivotal wins for an oral JAK inhibitor in an inflammatory skin condition. But with the placebo ...

A comparative study will be conducted to demonstrate the efficacy, safety, and equivalence between Cosentyx and CT-P55. CT-P55 received IND approval from the U.S. Food and Drug Administration (FDA ...

HSBC lowered its target price for Sun Pharmaceuticals to ₹2,000, maintaining a ’buy’ rating. The revision reflects clinical ...

This medication is also sometimes used to treat ... Other types of biologics, such as ixekizumab (Taltz) or secukinumab (Cosentyx), may be used when initial treatment with spesolimab or infliximab ...

indicating robust demand for this drug class. Reported global sales for key anti-IL brands (including Cosentyx, Taltz, Stelara, Tremfya, and Skyrizi) grew to ₹36 billion in 2024 from ₹13 ...